The new biopharmaceutical blueprint.
| Publicado en: | Pharmaceutical Technology Europe Vol. 20; no. 4; pp. 79 - 85 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Apr2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108045130&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108045130 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Apr2008 vid: 20 iid: 4 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 108045130 2011971518 108045130 ppf: 79 ppct: 6 formats: fmt: @attributes: type: P tig: atl: The new biopharmaceutical blueprint. aug: au: Deurinck, Pieter Dimare, Jay Ricci, Michael Martin, Kathleen sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|